Invivotek (InVivotek, LLC) is a preclinical CRO operating as part of Genesis Drug Discovery & Development (GD3), a fully integrated CRO supporting drug discovery from target discovery through IND filing and clinical trials. The company specializes in translational studies, in vivo pharmacology, disease modeling (with 150+ PDX models), PK/PD studies, and toxicology in an AAALAC-accredited facility.
preclinical disease modeling, in vivo pharmacology, PK/PD studies, xenograft tumor models, toxicology, ADC evaluation
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.